Inventor
ZHANG WEIHE
US40 patents
⚠️ This page may combine multiple inventors who share the name “ZHANG WEIHE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BIOCRYST PHARM INC
28 patentsUS10329260B2Jun 25, 2019
Human plasma kallikrein inhibitors
BIOCRYST PHARM INC26 citations98
US10125102B2Nov 13, 2018
Human plasma kallikrein inhibitors
BIOCRYST PHARM INC24 citations98
US10689346B2Jun 23, 2020
Human plasma kallikrein inhibitors
BIOCRYST PHARM INC10 citations92
US10633345B2Apr 28, 2020
Human plasma kallikrein inhibitors
BIOCRYST PHARM INC10 citations92
US11708332B2Jul 25, 2023
Human plasma kallikrein inhibitors
BIOCRYST PHARM INC2 citations84
US11708333B2Jul 25, 2023
Human plasma kallikrein inhibitors
BIOCRYST PHARM INC2 citations84
US11230530B2Jan 25, 2022
Human plasma kallikrein inhibitors
BIOCRYST PHARM INC5 citations84
US11203574B2Dec 21, 2021
Human plasma kallikrein inhibitors
BIOCRYST PHARM INC5 citations84
US11192861B2Dec 7, 2021
Human plasma kallikrein inhibitors
BIOCRYST PHARM INC5 citations84
US11370774B2Jun 28, 2022
Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitors
BIOCRYST PHARM INC4 citations83
US11021458B2Jun 1, 2021
Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitors
BIOCRYST PHARM INC5 citations83
US12162838B2Dec 10, 2024
Human plasma kallikrein inhibitors
BIOCRYST PHARM INC0 citations73
US12116346B2Oct 15, 2024
Human plasma kallikrein inhibitors
BIOCRYST PHARM INC0 citations73
US11685721B2Jun 27, 2023
Human plasma kallikrein inhibitors
BIOCRYST PHARM INC2 citations73
US11559515B2Jan 24, 2023
Indole compounds and analogues thereof
BIOCRYST PHARM INC2 citations73
US10849883B2Dec 1, 2020
Benzopyrazole compounds and analogues thereof
BIOCRYST PHARM INC3 citations73
US10562850B2Feb 18, 2020
Human plasma kallikrein inhibitors
BIOCRYST PHARM INC2 citations73
US12043610B2Jul 23, 2024
Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitors
BIOCRYST PHARM INC1 citations72
US11866418B2Jan 9, 2024
Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitors
BIOCRYST PHARM INC2 citations72
US11708347B2Jul 25, 2023
Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitors
BIOCRYST PHARM INC3 citations72
US11661426B2May 30, 2023
Imidazole-containing inhibitors of ALK2 kinase
BIOCRYST PHARM INC2 citations72
US12485109B2Dec 2, 2025
Pyrrolo 12.3-dipyrimidine compounds and analogues thereof
BIOCRYST PHARM INC0 citations62
US12054492B2Aug 6, 2024
Imidazole-containing inhibitors of ALK2 kinase
BIOCRYST PHARM INC0 citations62
US11807605B2Nov 7, 2023
Human plasma kallikrein inhibitors
BIOCRYST PHARM INC0 citations62
US11618731B2Apr 4, 2023
Prodrugs of kallikrein inhibitors
BIOCRYST PHARM INC0 citations62
US11066360B2Jul 20, 2021
Human plasma kallikrein inhibitors
BIOCRYST PHARM INC1 citations62
US10759759B2Sep 1, 2020
Prodrugs of kallikrein inhibitors
BIOCRYST PHARM INC1 citations62
US12558341B2Feb 24, 2026
Oral complement factor D inhibitors
BIOCRYST PHARM INC0 citations48
UNIV NORTH CAROLINA CHAPEL HILL
10 patentsUS10004755B2Jun 26, 2018
Therapeutic uses of selected pyrrolopyrimidine compounds with anti-mer tyrosine kinase activity
UNIV NORTH CAROLINA CHAPEL HILL8 citations84
US9555031B2Jan 31, 2017
Therapeutic uses of selected pyrrolopyrimidine compounds with anti-mer tyrosine kinase activity
UNIV NORTH CAROLINA CHAPEL HILL4 citations84
US9649309B2May 16, 2017
Therapeutic uses of selected pyrimidine compounds with anti-Mer tyrosine kinase activity
UNIV NORTH CAROLINA CHAPEL HILL2 citations73
US9795606B2Oct 24, 2017
Pyrrolopyrimidine compounds for the treatment of cancer
UNIV NORTH CAROLINA CHAPEL HILL2 citations72
US9562047B2Feb 7, 2017
Pyrazolopyrimidine compounds for the treatment of cancer
UNIV NORTH CAROLINA CHAPEL HILL3 citations72
US9567326B2Feb 14, 2017
Pyrimidine compounds for the treatment of cancer
UNIV NORTH CAROLINA CHAPEL HILL3 citations71
US10179133B2Jan 15, 2019
Pyrrolopyrimidine compounds for the treatment of cancer
UNIV NORTH CAROLINA CHAPEL HILL0 citations51
US9744172B2Aug 29, 2017
Pyrazolopyrimidine compounds for the treatment of cancer
UNIV NORTH CAROLINA CHAPEL HILL0 citations51
US11001586B2May 11, 2021
Alkyl pyrrolopyrimidine analogs and methods of making and using same
UNIV NORTH CAROLINA CHAPEL HILL0 citations46
US9771330B2Sep 26, 2017
Pyrimidine compounds for the treatment of cancer
UNIV NORTH CAROLINA CHAPEL HILL0 citations40